Rigel Pharmaceuticals Inc (RIGL)
1.09
-0.01
(-0.91%)
USD |
NASDAQ |
Apr 26, 16:00
1.09
0.00 (0.00%)
After-Hours: 16:08
Rigel Pharmaceuticals Gross Profit (Quarterly): 32.00M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 32.00M |
September 30, 2023 | 26.87M |
June 30, 2023 | 25.81M |
March 31, 2023 | 25.09M |
December 31, 2022 | 50.94M |
September 30, 2022 | 22.16M |
June 30, 2022 | 28.78M |
March 31, 2022 | 16.61M |
December 31, 2021 | 19.92M |
September 30, 2021 | 21.39M |
June 30, 2021 | 26.14M |
March 31, 2021 | 80.70M |
December 31, 2020 | 18.13M |
September 30, 2020 | 18.25M |
June 30, 2020 | 15.74M |
March 31, 2020 | 55.61M |
December 31, 2019 | 15.22M |
September 30, 2019 | 20.55M |
June 30, 2019 | 10.10M |
March 31, 2019 | 12.52M |
December 31, 2018 | 37.67M |
September 30, 2018 | 4.796M |
June 30, 2018 | 1.757M |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
Date | Value |
---|---|
September 30, 2017 | 0.90M |
June 30, 2017 | 0.00 |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 | 4.355M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
10.10M
Minimum
Jun 2019
80.70M
Maximum
Mar 2021
27.90M
Average
22.16M
Median
Sep 2022
Gross Profit (Quarterly) Benchmarks
Nektar Therapeutics | 16.60M |
Avid Bioservices Inc | 2.383M |
Stereotaxis Inc | 2.738M |
Cara Therapeutics Inc | 2.396M |
Blueprint Medicines Corp | 71.70M |